Skip to main content
. 2019 Aug 8;19:185. doi: 10.1186/s12866-019-1551-2

Table 2.

Distributions of resistance and virulence-related genes in GBS recovered from neonates and pregnant women, respectively

Resistance/virulence-related genes No. of isolates
EOGBS LOGBS NCGBS MCGBS
ERY and CLI resistance genesa
ermB 4 8 8 11
mefA/E 1 10
lnuB 1
ermB, mefA/E 1 2 6d
ermB, lnuB 3 6 2 5
mefA/E, lnuB 1 2
mefA/E, lnuD 6
ermB, mefA/E, lnuB 2
ermTR, mefA/E 1d
TET resistance genesb
TetO 1 4 5 9
TetM 1 37
TetS 1 1
TetO, TetM 8 11 4 2
TetM, TetS 1
TetO, TetM, TetL 1 2 1
TetO, TetM, TetK 1
Virulence-related genesc
hylB 4
hylB, lmb 1 2 4
hylB, scpB 1
hylB, lmb, scpB 9 15 3 44
hylB, lmb, bca 1
hylB, lmb, scpB, bac 1 4 4
hylB, lmb, scpB, bac, bca 2 1 2

ERY erythromycin, CLI clindamycin, TET tetracycline EOGBS early-onset GBS, LOGBS late-onset GBS, NCGBS neonatal colonizing GBS, MCGBS maternal colonizing GBS

a 36 and 44 isolates of erythromycin and/or clindamycin resistant/intermediate GBS were detected in neonates and pregnant women, respectively

b 39 and 51 isolates of tetracycline resistant GBS were detected in neonates and pregnant women, respectively

c 41 and 57 isolates of GBS were detected in neonates and pregnant women, respectively

d Inducible clindamycin resistance was detected in GBS isolate for each one, respectively